Terence Ketter
Academic Appointments
Key Documents
Contact Information
-
Clinical Offices
Psychiatry Department 401 Quarry Rd MC 5723 Stanford, CA 94305 Tel Work (650) 723-2515 Fax (650) 723-2507
- Academic Offices
Personal Information Email Tel (650) 723-2515Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Psychiatry
- Bipolar Disorder
- Psychopharmacology
Administrative Appointments
- Chief, Bipolar Disorders Clinic (1995 - present)
Honors and Awards
- Distinguished Fellow, American Psychiatric Association (2006)
- Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (2003-2005)
- Outstanding Faculty Physician Award, Vaden Health Center, Stanford University (2002)
- Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (1999-2001)
- Independent Investigator Award, Stanley Foundation Research Award Program (1996-2000)
- Mead Johnson Travel Award Fellow, American College of Neuropsychopharmacology (1994)
Professional Education
| Residency: | UCSF Medical Center CA (1988) |
| Fellowship: | National Institute of Health MD (1995) |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (1989) |
| Internship: | UCSF Medical Center CA (1985) |
| Medical Education: | University of Toronto, Canada (1984) |
| BSc: | University of Toronto, Mathematics (1973) |
Graduate & Fellowship Program Affiliations
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Dr. Ketter has done extensive research into the etiology, phenomenology, and treatment of bipolar disorder. His etiologic research has focused on the use of brain imaging methods such as magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET) to better understand the neurobiology of mood disorders and to explore the possibility of using these techniques to more effectively target treatments for patients with bipolar disorder. His phenomenologic research has focused on the development and course of bipolar disorder in late adolescence and young adulthood, particularly in college students, and links between creativity, temperament, and mood disorders. His research into treatment has involved clinical trials of novel medications and combinations of medications in the treatment of bipolar disorder, with an emphasis on the use of anticonvulsants.
Publications
- Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. J Psychiatr Res. 2013; (2): 252-8
- First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo. J Affect Disord. 2013
- Addressing challenges in bipolar diagnosis: what do good clinicians already do? An editorial comment to Phelps J, Ghaemi SN 'The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11'. Acta Psychiatr Scand. 2012; (6): 393-4
- Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther. 2012; (3): 243-9
- Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disord. 2012; (1): 41-53
- Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder. J Clin Psychopharmacol. 2012; (6): 814-9
Help